Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-01

FDA Approved: CLOBAZAM — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CLOBAZAM (clobazam) submitted by Camber Pharmaceuticals, Inc. This action represents regulatory approval of a su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)